Biotts (www.biotts.com) is a clinical-stage biotech company with a pipeline of proprietary drug candidates in oncology, diabetology, and pain.
Biotts' extensive pipeline of drug candidates rely on a breakthrough technology of a universal transdermal drug delivery where the properties of the novel and patented carrier enable one or multiple molecules to penetrate through the skin regardless of size, increase bioavailability, reduce the therapeutic dose and reduce the side effects.
Biotts' flagship product MTC-D1 has entered the clinical stage of drug development in diabetes.
Biotts' extensive pipeline of drug candidates rely on a breakthrough technology of a universal transdermal drug delivery where the properties of the novel and patented carrier enable one or multiple molecules to penetrate through the skin regardless of size, increase bioavailability, reduce the therapeutic dose and reduce the side effects.
Biotts' flagship product MTC-D1 has entered the clinical stage of drug development in diabetes.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
